Listed

Odyssey Therapeutics, Inc.

ODTXNasdaqCIK 1882782HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$55.5m, Q2 FY2026
Net income−$52.8m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1.9Revenue, period not labelled, three months to 2025-03-31$1.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure1.0Revenue, period not labelled, three months to 2025-06-30$959.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Research and development$m38.8Research and development, period not labelled, three months to 2025-03-31$38.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure30.2Research and development, period not labelled, three months to 2025-06-30$30.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure32.3Research and development, Q1 FY2026, three months to 2026-03-31$32.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure36.2Research and development, Q2 FY2026, three months to 2026-06-30$36.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Operating income$m(39.2)Operating income, period not labelled, three months to 2025-03-31−$39.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(41.9)Operating income, period not labelled, three months to 2025-06-30−$41.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(39.8)Operating income, Q1 FY2026, three months to 2026-03-31−$39.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(55.5)Operating income, Q2 FY2026, three months to 2026-06-30−$55.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Interest expense$m0.0Interest expense, period not labelled, three months to 2025-03-31$2.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure0.0Interest expense, period not labelled, three months to 2025-06-30$2.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$10.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$20.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Income tax$m0.1Income tax, period not labelled, three months to 2025-03-31$140.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure0.0Income tax, period not labelled, three months to 2025-06-30$30.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$63.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(0.0)Income tax, Q2 FY2026, three months to 2026-06-30−$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Net income$m(38.4)Net income, period not labelled, three months to 2025-03-31−$38.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(41.2)Net income, period not labelled, three months to 2025-06-30−$41.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(38.3)Net income, Q1 FY2026, three months to 2026-03-31−$38.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(52.8)Net income, Q2 FY2026, three months to 2026-06-30−$52.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Diluted EPS$ per share(39.37)Diluted EPS, period not labelled, three months to 2025-03-31−$39.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(29.54)Diluted EPS, period not labelled, three months to 2025-06-30−$29.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(6.77)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$6.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(1.74)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Basic EPS$ per share(39.37)Basic EPS, period not labelled, three months to 2025-03-31−$39.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(29.54)Basic EPS, period not labelled, three months to 2025-06-30−$29.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(6.77)Basic EPS, Q1 FY2026, three months to 2026-03-31−$6.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(1.74)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure

Balance sheet

Cash and equivalents$82.0m, Q2 FY2026
Shareholders' equity$421.2m, Q2 FY2026
Line itemUnitperiod not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30period not labelled2025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported54.9Cash and equivalents, period not labelled, at 2025-03-31$54.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure163Cash and equivalents, period not labelled, at 2025-06-30$163.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure41.7Cash and equivalents, period not labelled, at 2025-12-31$41.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure35.7Cash and equivalents, Q1 FY2026, at 2026-03-31$35.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure82.0Cash and equivalents, Q2 FY2026, at 2026-06-30$82.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Current assets$mnot reportednot reportednot reported191Current assets, period not labelled, at 2025-12-31$190.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure185Current assets, Q1 FY2026, at 2026-03-31$185.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure321Current assets, Q2 FY2026, at 2026-06-30$321.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Total assets$mnot reportednot reportednot reported270Total assets, period not labelled, at 2025-12-31$269.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure229Total assets, Q1 FY2026, at 2026-03-31$229.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure484Total assets, Q2 FY2026, at 2026-06-30$483.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Current liabilities$mnot reportednot reportednot reported26.5Current liabilities, period not labelled, at 2025-12-31$26.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure22.2Current liabilities, Q1 FY2026, at 2026-03-31$22.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure28.3Current liabilities, Q2 FY2026, at 2026-06-30$28.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Total liabilities$mnot reportednot reportednot reported54.5Total liabilities, period not labelled, at 2025-12-31$54.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure49.2Total liabilities, Q1 FY2026, at 2026-03-31$49.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure62.6Total liabilities, Q2 FY2026, at 2026-06-30$62.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure
Shareholders' equity$m(383)Shareholders' equity, period not labelled, at 2024-12-31−$382.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(417)Shareholders' equity, period not labelled, at 2025-03-31−$417.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(436)Shareholders' equity, period not labelled, at 2025-06-30−$436.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(488)Shareholders' equity, period not labelled, at 2025-12-31−$488.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure(524)Shareholders' equity, Q1 FY2026, at 2026-03-31−$523.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure421Shareholders' equity, Q2 FY2026, at 2026-06-30$421.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure

Cash flow

Operating cash flow−$34.5m, Q2 FY2026
Capital expenditure$186.0k, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(38.6)Operating cash flow, period not labelled, three months to 2025-03-31−$38.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(34.3)Operating cash flow, period not labelled, three months to 2025-06-30−$34.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-335822. Derived: 6-month figure less the 3-month figure.Report this figure(41.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$41.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure(34.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$34.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-335822. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.9Capital expenditure, period not labelled, three months to 2025-03-31$927.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure0.0Capital expenditure, period not labelled, three months to 2025-06-30$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-335822. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$148.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$186.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-335822. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)30.28m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.0Diluted shares (weighted), period not labelled, three months to 2025-03-31976,146 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure1.4Diluted shares (weighted), period not labelled, three months to 2025-06-301,395,695 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure5.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-315,655,716 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-06-17, accession 0001193125-26-274290.Report this figure30.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3030,277,051 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure

Shares outstanding: 48.06mShares outstanding, period not labelled, at 2026-08-0348,058,527 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-335822.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.